Detalhe da pesquisa
1.
Trial of Intravenous Immune Globulin in Dermatomyositis.
N Engl J Med
; 387(14): 1264-1278, 2022 10 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36198179
2.
Belimumab treatment of adult idiopathic inflammatory myopathy.
Rheumatology (Oxford)
; 63(3): 742-750, 2024 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37326854
3.
Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis.
Rheumatology (Oxford)
; 2024 Mar 09.
Artigo
Inglês
| MEDLINE | ID: mdl-38460548
4.
Current status of clinical outcome measures in inclusion body myositis: a systematised review.
Clin Exp Rheumatol
; 41(2): 370-378, 2023 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-36762744
5.
HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry.
Proc Natl Acad Sci U S A
; 117(1): 552-562, 2020 01 07.
Artigo
Inglês
| MEDLINE | ID: mdl-31871193
6.
Photoacoustic Imaging of COVID-19 Vaccine Site Inflammation of Autoimmune Disease Patients.
Sensors (Basel)
; 23(5)2023 Mar 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36904999
7.
Comparative Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccines Against the Delta Variant.
Clin Infect Dis
; 75(1): e623-e629, 2022 08 24.
Artigo
Inglês
| MEDLINE | ID: mdl-35137006
8.
Efficacy of COVID-19 vaccines in patients taking immunosuppressants.
Ann Rheum Dis
; 81(6): 875-880, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35197265
9.
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial.
Ann Rheum Dis
; 79(5): 618-625, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32299845
10.
Reliability, construct validity and responsiveness to change of the PROMIS-29 in systemic sclerosis-associated interstitial lung disease.
Clin Exp Rheumatol
; 37 Suppl 119(4): 49-56, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31498073
11.
The sphingosine-1-phosphate receptor: A novel therapeutic target for multiple sclerosis and other autoimmune diseases.
Clin Immunol
; 175: 10-15, 2017 02.
Artigo
Inglês
| MEDLINE | ID: mdl-27890706
12.
Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry.
Clin Exp Rheumatol
; 35 Suppl 106(4): 106-113, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-27908301
13.
Scleroderma dermal microvascular endothelial cells exhibit defective response to pro-angiogenic chemokines.
Rheumatology (Oxford)
; 55(4): 745-54, 2016 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-26705326
14.
A phase 2, double-blinded, placebo-controlled trial of toll-like receptor 7/8/9 antagonist, IMO-8400, in dermatomyositis.
J Am Acad Dermatol
; 84(4): 1160-1162, 2021 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-32781178
15.
Prevalence of subclinical atherosclerosis is increased in systemic sclerosis and is associated with serum proteins: a cross-sectional, controlled study of carotid ultrasound.
Rheumatology (Oxford)
; 53(4): 704-13, 2014 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-24357811
16.
Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM study.
Arthritis Res Ther
; 26(1): 27, 2024 01 17.
Artigo
Inglês
| MEDLINE | ID: mdl-38233885
17.
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trial.
Lancet Rheumatol
; 5(11): e660-e669, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-38251533
18.
Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry.
Ann Rheum Dis
; 71(8): 1335-42, 2012 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-22307943
19.
Successful use of secukinumab in two melanoma patients with immune checkpoint inhibitor-induced inflammatory arthropathy.
Immunotherapy
; 14(8): 593-598, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35416067
20.
COVID-19 vaccine effectiveness against omicron (B.1.1.529) variant infection and hospitalisation in patients taking immunosuppressive medications: a retrospective cohort study.
Lancet Rheumatol
; 4(11): e775-e784, 2022 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-35991760